Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Healx Ltd.
BioCentury | Dec 5, 2024
Management Tracks
Várhelyi to lead health at EU
Plus updates from Nouscom, Eton, Healx, Medipost, Fairjourney, Italfarmaco and Cellino
BioCentury | Aug 1, 2024
Finance
Venture Report: venBio closes new $528M fifth fund
Plus: Airna, ReviR, LTZ and Synthetica draw Series A cash, while Outpace, Confo and Healx refill their coffers
BioCentury | Aug 20, 2022
Deals
How Ultragenyx delivered win for biotech venture philanthropy via GeneTx deal
Rare disease company invested in a spinout of a non-profit that was making science decisions, not just writing checks
BioCentury | Feb 11, 2022
Deals
Feb. 10 Quick Takes: RA, Adjuvant ready Curevo to take on Shingrix with $60M A round
Seagen slides on guidance, and updates from Arkuda, Altesa, Aeglea, Congruence, 1859 and more
BioCentury | Jun 20, 2020
Management Tracks
Nurix bolsters leadership; plus Lynch named Xilio chairman, Edgewise, BioXCel, Catabasis, Catalyst and more
BioCentury | Oct 16, 2019
Company News
AI play Healx raises $56M to repurpose drugs for rare disease
How Healx is tackling rare diseases using AI and input from patient groups
BioCentury | Jul 11, 2019
Company News
Management tracks: President of Lilly BioMedicines steps down to lead Kite; plus Alnylam, GSK, and more
Items per page:
1 - 7 of 7